Project Grant R21AI189268
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$227K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14642, USA
Similar Awards
This federal Project Grant award, totaling $472,210.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to investigate the spatiotemporal relationship between CD4+ T resident memory cells and neutrophil recruitment in the lungs during pneumonia, while developing a transcriptional atlas of immune processes in the experienced lung. Key objectives include...
This Project Grant award, totaling $831,755, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine. The funding supports research to investigate the role of lung-resident macrophage subsets, particularly nerve- and airway-associated macrophages (NAMs), in regulating type 2 immune responses and trained immunity following infections that trigger a robust...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $232,073 Project Grant (R21AI186688) to The Research Foundation For The State University Of New York (Stony Brook University) to explore the host-pathogen dynamics between the fungal pathogen Cryptococcus neoformans (CN) and HIV in microglia, the predominant immune cells in the brain. The overarching goal is to investigate how the accumulation...
The federal Project Grant award R21AI190747, totaling $249,749.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant supports research by the University of Iowa to develop a new approach for analyzing the transcriptional control of virulence in the human fungal pathogen Aspergillus fumigatus. The research aims to enable time-dependent proteolytic removal of key transcription...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA 93.855 Allergy and Infectious Diseases Research, is focused on developing a molecular toolbox for the fungal pathogen Pneumocystis jirovecii. The key objectives are to establish a transformation system using CRISPR/Cas9 gene editing and plasmid-mediated approaches, which will enable functional studies on the biology and pathogenesis of Pneumocystis infection. The $402,860 award, with a...
This Project Grant award of $750,815, provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research), supports research aimed at developing novel anti-infective strategies to treat pulmonary mucormycosis, a deadly invasive fungal infection. The key objectives are to: 1) examine the role of the host cell hypoxia-response pathway, specifically the protein ANGPTL4, in the pathogenesis of mucormycosis and explore its therapeutic...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA 93.855 Allergy and Infectious Diseases Research, provides $239,348 to The Trustees of Columbia University in the City of New York to conduct research on the impact of regulatory T cells (Tregs) on host susceptibility to Pseudomonas aeruginosa infection. The key objectives are to evaluate whether Tregs protect against P. aeruginosa pneumonia by altering the airway metabolome...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $689,068 to the University of Cincinnati to establish ex vivo growth systems for the fungal genus Pneumocystis, which causes a life-threatening pneumonia in immunodeficient individuals. The key objectives are to: 1) Use metabolomics and flux balance analysis to identify critical nutrients for growing the surrogate...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $749,594 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation For The State University Of New York, doing business as Stony Brook University. The grant, effective from February 1, 2025 to January 31, 2030, supports research to study the role of the host sphingosine kinase 1 (SK1) pathway in controlling Cryptococcus neoformans infection during...
This $722,958 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to investigate the role of monocyte-derived galectin-1 in promoting tissue-resident memory T cell responses to influenza infection. The research seeks to (1) elucidate the differentiation of monocytes during immune memory formation after influenza infection, (2) determine how galectin-1 produced by a novel...